Structure Therapeutics
Stock Forecast, Prediction & Price Target

Structure Therapeutics Financial Estimates

Structure Therapeutics Revenue Estimates

Structure Therapeutics EBITDA Estimates

Structure Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $55.55M
Low: $55.55M
High: $55.55M
avg. 0%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $148.8M
Low: $148.8M
High: $148.8M
avg. 0%
Avg: $199.5M
Low: $199.5M
High: $199.5M
avg. 34.07%
Net Income
 
% change YoY
$-38.04K
 
N/A
$-51.32M
 
-134781.33%
$-89.62M
 
-74.62%
Avg: $-122.73M
Low: $-58.77M
High: $90.72M
avg. -36.95%
Avg: $-226.02M
Low: $-73.09M
High: $-40.40M
avg. -84.15%
Avg: $-60.60M
Low: $-60.60M
High: $-60.60M
avg. 73.18%
Avg: $-40.22M
Low: $-40.22M
High: $-40.22M
avg. 33.63%
EBITDA
 
% change YoY
$-37.62K
 
N/A
$-52.56M
 
-139600.72%
$-102.77M
 
-95.53%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0
 
N/A
-$1.4
 
-139900%
-$2.44
 
-74.28%
Avg: -$0.81
Low: -$1.6
High: $2.47
avg. 66.92%
Avg: -$1.6
Low: -$1.99
High: -$1.1
avg. -97.92%
Avg: -$1.65
Low: -$1.65
High: -$1.65
avg. -3.28%
Avg: -$1.1
Low: -$1.1
High: -$1.1
avg. 33.63%
Operating Expenses
 
% change YoY
$37.69K
 
N/A
$52.56M
 
139333.89%
$102.77M
 
95.53%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Structure Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -3.57% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is -58.77M, average is -122.73M and high is 90.72M.

What is Structure Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 8.51% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $55.55M, average is $55.55M and high is $55.55M.

What is Structure Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -0.16% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.6, average is -$0.81 and high is $2.47.

What is the best performing analyst?

In the last twelve months analysts have been covering Structure Therapeutics stock. The most successful analyst is Evan Seigerman.